Cabernet Pharmaceuticals, Inc.

Cabernet Pharmaceuticals has assembled an international team of professionals with deep experience across the spectrum of pharmaceutical research and development. The team draws from staff at Cabernet and its sister company Zinfandel Pharmaceuticals, from allied consulting firms, and from academic researchers. It includes scientists who have contributed to seminal work in identifying and using biomarkers to enable innovative clinical development and who have worked with regulatory authorities to incorporate new scientific understanding into clinical-trial design and analyses of safety and efficacy. These scientists have held direct or collaborative roles with large pharmaceutical corporations, biotechnology companies, and academic research institutions. They typically have at least 25 years of experience relevant to advancing new medicines to the marketplace. From this team Cabernet can flexibly match the right group of consultants to each client’s drug-development needs at each stage of the development process.

BioDigitalValley

After more than 20 years of experience in the field of software production for banking and insurances, the RGI Group decided to start exploring a new, fascinating and highly innovative market: bioinformatics. To this aim, a process of scouting for projects and people was started, which coagulated in BioDigitalValley, a company dedicated to invent, develop and commercialize new solutions for bio-research, e-health and drug discovery. After the initial start-up phase, the goal of BioDigitalValley is to place RGI within five years in the mainstream of bioinformatics, then being in a consolidated position on the market while benefiting the potential consumer with new, advanced solutions. This vision leads to a two-pronged mission of BioDigitalValley namely: • To provide the information, tools, research, capacity development and solutions to serve the development and exploitation of bioinformatics, drug discovery, e-health and the corresponding services • To ensure that the rapidly accumulating body of information from molecular, high throughput biology and bio-medicine will be translated into highly innovative products.

north carolina clinical research

launchmaps

sens research foundation